Alembic Pharmaceuticals Ltd (APLLTD) — Announcement | 27 August 2026 (2 announcements)

27 August 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

1Announcement🔴 High Importance Neutral📄 PDF

📢 Key Event

Alembic schedules one-on-one investor meetings for September 1-2, 2026

💡 Investor Takeaway

These meetings offer investors direct access to management to discuss performance and strategy.

Alembic Pharmaceuticals announced a series of one-on-one investor and analyst meetings scheduled for September 1-2, 2026, in Mumbai and via virtual conference, providing a platform for direct engagement with key financial stakeholders ahead of the next reporting cycle.

2Announcement🔴 High Importance Neutral📄 PDF

📢 Key Event

Alembic schedules one-on-one investor meetings for September 1-2, 2026

💡 Investor Takeaway

These meetings offer investors direct access to management to discuss performance and strategy.

📊 Stock Analysis — APLLTD ✨ Ask AI About This

About Alembic Pharmaceuticals Ltd (APLLTD)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹16,905.41 CrP/E: 24.4ROE: 12.2%ROCE: 11.7%Div Yield: 1.40%

View full APLLTD stock details →

📡 Get AI alerts when APLLTD files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track APLLTD — Free

💡 Ask AI about this filing

"What strategic priorities will management highlight in these meetings?""How does Alembic plan to address pricing pressures in key markets?""What is the expected timeline for new product launches?"

Ask AI Free →

📊 More APLLTD filings

Announcement — 28 September 2026Alembic Pharmaceuticals announced that its trading window will close on October 1, 2026, and remain ...
🔴 Announcement — 18 September 2026Alembic Pharmaceuticals announced one-to-one investor and analyst meetings in Mumbai on September 23...
🔴 Announcement — 16 September 2026Alembic Pharmaceuticals announced that the USFDA closed its inspection of the Vadodara bioequivalenc...
🔴 Announcement — 11 September 2026Alembic Pharmaceuticals announced the successful completion of an unannounced USFDA onsite bioequiva...
🔴 Announcement — 7 September 2026Alembic Pharmaceuticals announced the incorporation of its wholly owned subsidiary, Alembic Pharmace...

See all APLLTD filings →

🔥 Also filed on 27 August 2026

JNPRJuniper Green Energy LtdFinancial Results AWFISAWFIS Space Solutions LtdAnnual Report 509084Photon Capital Advisors LtdAnnual Report GUJALKALIGujarat Alkalies & Chemicals LtdAnnual Report EPACKEpack Durable LtdAnnual Report 538546Bansal Roofing Products LtdCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when APLLTD files new disclosures

Track APLLTD filings, board meetings, and corporate actions. Free email alerts at 5 PM.